Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Join | Sign in
Home>Products>Product News
  Service News
Imperial Innovations Leads £50 Million Series B Funding Round in Cell Medica
Tuesday, November 25, 2014
Cell Medica will use the investment capital to progress further the development of cellular immunotherapy products.

Clustering Effect Translates into Major Growth for BioPharma Specialist
Saturday, October 25, 2014
Company manages translation and linguistic validation projects.

New Accessories for the Mastersizer 3000 from Malvern Instruments
Friday, October 17, 2014
New accessories support smarter pharmaceutical particle size analysis.

FUJIFILM Diosynth Biotechnologies Announces the Launch of ‘Apollo™’
Thursday, October 09, 2014
New mammalian expression platform designed to create a robust ‘manufacturing-ready’ cell line.

The Lancet: Remote Monitoring Can Save ICD and CRT-D Patients' Lives
Tuesday, August 19, 2014
BIOTRONIK Home Monitoring reduces mortality and improves clinical outcomes in patients with heart failure.

Eurofins Genomics Adds NGS to ISO17025 Accredited Testing Portfolio
Saturday, August 16, 2014
ISO17025 accreditation to consistently offer valid results for testing in the fields of veterinary medicine, pharmaceuticals, food and animal feed, commodities and health care.

BD BACTEC FX40 Blood Culture Instrument Now Communicates with the BD EpiCenter Data Management System
Saturday, June 14, 2014
Low-Volume Clinical Laboratories Now Have Access to Advanced Data Management with New Blood Culture Instrument Connectivity

New MCO-170AIC CO2 incubator from Panasonic demonstrates exceptional control and optimises cell culture productivity
Monday, June 09, 2014
New MCO-170AIC CO2 incubators from Panasonic deliver outstanding quality in performance, maximise cell culture efficiency and provide optimum results and reproducibility. Designed specifically for the safe, consistent cultivation of successful cell lines, this latest innovation offers the very highest levels of precision, security and ease of use.

Nanobiotix Presents Successful Phase I Results for NBTXR3 at ASCO
Tuesday, June 03, 2014
Final results demonstrate a very good safety, treatment feasibility and promising signs of efficacy in patients with advanced Soft Tissue Sarcomas.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 306
Scientific News
Human Trials of Manufactured Blood Within Two Years
The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.
New Medication for Alcohol Use Disorder
NIH begins clinical trial investigating a potential treatment for alcohol use disorder.
Behavior Matters: Redesigning the Clinical Trial
A recent meta-analysis of six such clinical trials shows that behavior can have a serious impact on the effectiveness of a treatment and that the currently used DBRCT procedures may not be able to assess the effects of behavior on the treatment.
New Commercial Method for Producing Medical Isotope
The effort to secure a stable, domestic source of a critical medical isotope reached an important milestone this month as scientists demonstrated the production, separation and purification of molybdenum-99 (Mo-99.
NCI-MATCH Trial will Link Targeted Cancer Drugs to Gene Abnormalities
Precision medicine trial will open to patient enrollment in July.
Linking Targeted Cancer Drugs to Gene Abnormalities
Investigators at the NIH have announced a series of clinical trials that will study drugs or drug combinations that target specific genetic mutations.
IAOCR Welcomes Important Initial Step for Regulating European Clinical Trials
New regulation to ensure a more streamlined risk-based approach to the conduct of trials with more public openness about each trial and the results they produce.
Starting Antiretroviral Treatment Early Improves Outcomes for HIV-infected Individuals
NIH-funded trial results likely will impact global treatment guidelines.
Amgen Terminates Co-Development of Brodalumab with AstraZeneca
This move follows the release of clinical trial data which suggests the experimental drug has severe side effects.
Baylor, TGen Collaborate on Personalized Cancer Treatment Options
The companies will collaborate on precision medicine for cancer patients by offering liquid biopsies, performing gene sequencing, conducting clinical trials, and creating personalized vaccines.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters